|
|
|
|
LEADER |
01000caa a22002652c 4500 |
001 |
NLM165976292 |
003 |
DE-627 |
005 |
20250207165739.0 |
007 |
tu |
008 |
231223s2006 xx ||||| 00| ||jpn c |
028 |
5 |
2 |
|a pubmed25n0553.xml
|
035 |
|
|
|a (DE-627)NLM165976292
|
035 |
|
|
|a (NLM)17040057
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a jpn
|
100 |
1 |
|
|a Segawa, Naoki
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Bladder cancer with skin metastasis
|b a case report
|
264 |
|
1 |
|c 2006
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
500 |
|
|
|a Date Completed 14.11.2006
|
500 |
|
|
|a Date Revised 20.11.2014
|
500 |
|
|
|a published: Print
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a Bladder carcinoma with skin metastasis is extremely rare. We herein report a case of a bladder tumor with skin metastasis. A 68-year-old man was referred to our hospital with macroscopic hematuria. Cystoscopy revealed a trigone papillary tumor. Transurethral resection of bladder tumor (TURBT) was performed and the pathological diagnosis was transitional cell carcinoma (TCC), pT1, G3. Thereafter, he received several courses of TURBT, intravesical chemotherapy (pirarubicin, bacillus Calmette-Guerin and mitomycin C) and intra-arterial chemotherapy because of recurrence. Thirteen years later, he underwent total cystoprostatectomy with neobladder formation. Histological examination revealed muscle-invasive bladder cancer with a staging of T3bNOM0. Two years and three months later, multiple firm nodules with eruptions appeared on the skin in several regions; they were resected and the histological findings revealed TCC. This indicated metastatic spread from the primary bladder TCC. He received only supportive treatment during this period due to renal dysfunction. He died four months after the manifestation of the skin metastasis due to multiple metastases
|
650 |
|
4 |
|a Case Reports
|
650 |
|
4 |
|a English Abstract
|
650 |
|
4 |
|a Journal Article
|
650 |
|
7 |
|a Mitomycin
|2 NLM
|
650 |
|
7 |
|a 50SG953SK6
|2 NLM
|
650 |
|
7 |
|a Doxorubicin
|2 NLM
|
650 |
|
7 |
|a 80168379AG
|2 NLM
|
650 |
|
7 |
|a pirarubicin
|2 NLM
|
650 |
|
7 |
|a D58G680W0G
|2 NLM
|
650 |
|
7 |
|a Cisplatin
|2 NLM
|
650 |
|
7 |
|a Q20Q21Q62J
|2 NLM
|
650 |
|
7 |
|a Methotrexate
|2 NLM
|
650 |
|
7 |
|a YL5FZ2Y5U1
|2 NLM
|
700 |
1 |
|
|a Kotake, Yatsugu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Hamada, Syuji
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Takahara, Kiyoshi
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Azuma, Haruhito
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Katsuoka, Yoji
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Tsuji, Motomu
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Hinyokika kiyo. Acta urologica Japonica
|d 1962
|g 52(2006), 9 vom: 02. Sept., Seite 711-4
|w (DE-627)NLM012631779
|x 0018-1994
|7 nnas
|
773 |
1 |
8 |
|g volume:52
|g year:2006
|g number:9
|g day:02
|g month:09
|g pages:711-4
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_20
|
912 |
|
|
|a GBV_ILN_22
|
912 |
|
|
|a GBV_ILN_40
|
912 |
|
|
|a GBV_ILN_60
|
912 |
|
|
|a GBV_ILN_72
|
912 |
|
|
|a GBV_ILN_120
|
912 |
|
|
|a GBV_ILN_350
|
912 |
|
|
|a GBV_ILN_2001
|
912 |
|
|
|a GBV_ILN_2003
|
912 |
|
|
|a GBV_ILN_2005
|
912 |
|
|
|a GBV_ILN_2006
|
912 |
|
|
|a GBV_ILN_2008
|
912 |
|
|
|a GBV_ILN_2010
|
912 |
|
|
|a GBV_ILN_2012
|
912 |
|
|
|a GBV_ILN_2018
|
951 |
|
|
|a AR
|
952 |
|
|
|d 52
|j 2006
|e 9
|b 02
|c 09
|h 711-4
|